The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation
Fecal microbiota transplantation (FMT) is a promising treatment for microbiota dysbiosis associated diseases, such as Clostridioides difficile infection (CDI) and inflammatory bowel disease (IBD). The engraftment of donor bacteria is essential for the effectiveness of FMT, which to some extent depen...
Saved in:
| Main Authors: | Ruiqiao He, Pan Li, Jinfeng Wang, Bota Cui, Faming Zhang, Fangqing Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Gut Microbes |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2022.2100197 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improvement of the inflammation-damaged intestinal barrier and modulation of the gut microbiota in ulcerative colitis after FMT in the SHIME® model
by: Anna Kamlárová, et al.
Published: (2025-04-01) -
Effect of fecal microbiota transplantation on ulcerative colitis model in rats: The gut–brain axis
by: Mahdis Morshedbak, et al.
Published: (2025-02-01) -
Research progress on fecal microbiota transplantation in tumor prevention and treatment
by: Wu Yijia, et al.
Published: (2025-04-01) -
Exploring the role of gut microbiota in Parkinson’s disease: insights from fecal microbiota transplantation
by: Mengqi Guo, et al.
Published: (2025-06-01) -
Advancing prostate cancer treatment: the role of fecal microbiota transplantation as an adjuvant therapy
by: Rasoul Ebrahimi, et al.
Published: (2025-01-01)